Malignant Genitourinary System Neoplasm — Research

Malignant Genitourinary System Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-28	758	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab])`	2026-09-28	pubmed
Last 5 years	2021-01-01 → 2026-12-31	334	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-28	pubmed
Preceding 5-year window	2020-09-28 → 2025-09-27	302	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2020/09/28:2025/09/27[dp])`	2026-09-28	pubmed
Last 12 months	2025-09-28 → 2026-09-28	65	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2025/09/28:2026/09/28[dp])`	2026-09-28	pubmed
y2016	2016-01-01 → 2016-12-31	24	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-28	pubmed
y2017	2017-01-01 → 2017-12-31	34	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-28	pubmed
y2018	2018-01-01 → 2018-12-31	28	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-28	pubmed
y2019	2019-01-01 → 2019-12-31	45	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-28	pubmed
y2020	2020-01-01 → 2020-12-31	65	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-28	pubmed
y2021	2021-01-01 → 2021-12-31	57	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-28	pubmed
y2022	2022-01-01 → 2022-12-31	67	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-28	pubmed
y2023	2023-01-01 → 2023-12-31	53	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-28	pubmed
y2024	2024-01-01 → 2024-12-31	78	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-28	pubmed
y2025	2025-01-01 → 2025-12-31	60	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-28	pubmed

Data updated 4 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (888)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 676–700 of 888 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.
· Clin Cancer Res · 2013 · PMID 23620406 · validated civic_curation pubmed
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.
· J Pathol · 2002 · PMID 11793370 · validated civic_curation pubmed
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
· JAMA · 2012 · PMID 22274685 · validated civic_curation pubmed
EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.